Wells Fargo Maintains Equal-Weight on Amrize, Lowers Price Target to $39
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Wells Fargo analyst Timna Tanners maintains Amrize (NYSE:AMRZ) with a Equal-Weight and lowers the price target from $40 to $39.
Wells Fargo analyst Timna Tanners maintains Amrize (NYSE:AMRZ) with a Equal-Weight and lowers the price target from $40 to $39.